Dr Yves de LEVAL financials
A multi-period view of the public annual-account figures reported for Dr Yves de LEVAL, with comparable measures and links to available source documents.
Company overviewRegistry number
0888572062
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for Dr Yves de LEVAL
2025 versus 2024
- Operating line
- €245,772
- EBITDA
- €245,385
- Total assets
- €411,888
- Equity
- €158,142
+65.5%
+66.2%
+38.1%
+8.6%
EBITDA margin +99.8% · Equity ratio +38.4%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Jun 2025 | €245,772 | €245,385 | €411,888 | €158,142 | - |
| 202430 Jun 2024 | €148,546 | €147,687 | €298,210 | €145,671 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.